SCHEMBL32670543

SCHEMBL32670543

C=Cc1ccc(-c2ccc(Cl)cc2Cl)cc1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AHR P35869 2/20 0.52
SRD5A2 P31213 1/20 0.47
HSD11B1 P28845 3/20 0.44
ALDH1A1 P00352 2/20 0.42
MARS1 P56192 4/20 0.41
GRM2 Q14416 1/20 0.38
TP53 P04637 3/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.37
ALOX15 P16050 1/20 0.37
NFKB1 P19838 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2933108 0.81 AHR (0.67) AHRSRD5A2HSD11B1ALDH1A1MARS1
SCHEMBL1725545 0.81 HSD17B10 (0.56) AHRSRD5A2HSD11B1ALDH1A1MARS1
SCHEMBL5544016 0.78 AHR (0.57) AHRSRD5A2HSD11B1ALDH1A1MARS1
SCHEMBL8759091 0.77 CSNK2A1 (0.49) HSD11B1ALDH1A1TP53NPC1RAB9A
SCHEMBL4214945 0.77 ALDH1A1 (0.58) AHRALDH1A1KDM4EMAPT
SCHEMBL8757864 0.76 CYP2A6 (0.58) HSD11B1ALDH1A1TP53NPC1RAB9A
SCHEMBL11784870 0.74 TDP1 (0.50) AHRALDH1A1TP53KDM4EMAPT
SCHEMBL7136627 0.74 AHR (0.57) AHRSRD5A2HSD11B1ALDH1A1MARS1
SCHEMBL1513663 0.74 MEN1 (0.58) AHRSRD5A2MARS1SMN1; SMN2MAPT
SCHEMBL21723080 0.74 AHR (0.57) AHRSRD5A2HSD11B1ALDH1A1MARS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260034094-A1 COMPOSITIONS AND METHODS FOR INDUCING FERROPTOSIS KOJIN THERAPEUTICS INC (US) 2026-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260034094-A1 COMPOSITIONS AND METHODS FOR INDUCING FERROPTOSIS AIFM2, GPX4, HMOX1 AHR 1566/4885SRD5A2 1046/4885HSD11B1 947/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.